Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.
Read More…
Industry, Sector and Symbol
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
Phone31-20-420-3191
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$700.85 million
Profitability
Miscellaneous
Employees4,700
Next Earnings Date7/24/2019 (Estimated)
OptionableOptionable
Core Laboratories (NYSE:CLB) Frequently Asked Questions
What is Core Laboratories' stock symbol?
Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."
How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?
Core Laboratories declared a quarterly dividend on Tuesday, April 16th. Investors of record on Friday, April 26th will be given a dividend of $0.55 per share on Tuesday, May 21st. This represents a $2.20 annualized dividend and a yield of 4.26%. The ex-dividend date is Thursday, April 25th. View Core Laboratories' Dividend History.
How were Core Laboratories' earnings last quarter?
Core Laboratories (NYSE:CLB) released its earnings results on Wednesday, April, 24th. The oil and gas company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.01. The oil and gas company earned $169.19 million during the quarter, compared to the consensus estimate of $166.79 million. Core Laboratories had a net margin of 13.79% and a return on equity of 57.13%. The business's revenue for the quarter was down .5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.57 EPS. View Core Laboratories' Earnings History.
When is Core Laboratories' next earnings date?
What guidance has Core Laboratories issued on next quarter's earnings?
Core Laboratories updated its second quarter earnings guidance on Wednesday, April, 24th. The company provided earnings per share (EPS) guidance of $0.47-0.50 for the period, compared to the Thomson Reuters consensus estimate of $0.49. The company issued revenue guidance of $172-175 million, compared to the consensus revenue estimate of $174.35 million.Core Laboratories also updated its Q2 2019 guidance to $0.47-0.50 EPS.
What price target have analysts set for CLB?
15 brokerages have issued 12-month price objectives for Core Laboratories' shares. Their predictions range from $66.00 to $130.00. On average, they anticipate Core Laboratories' share price to reach $87.40 in the next twelve months. This suggests a possible upside of 69.2% from the stock's current price. View Analyst Price Targets for Core Laboratories.
What is the consensus analysts' recommendation for Core Laboratories?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.
Has Core Laboratories been receiving favorable news coverage?
Headlines about CLB stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Core Laboratories earned a media sentiment score of -1.2 on InfoTrie's scale. They also assigned news articles about the oil and gas company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Core Laboratories.
Who are some of Core Laboratories' key competitors?
Some companies that are related to Core Laboratories include Propetro (PUMP), Oceaneering International (OII), Liberty Oilfield Services (LBRT), RPC (RES), Franks International (FI), Select Energy Services (WTTR), Helix Energy Solutions Group (HLX), SemGroup (SEMG), C&J Energy Services (CJ), Keane Group (FRAC), National Energy Services Reunited (NESR), FTS International (FTSI), KLX Energy Services (KLXE), US Well Services (USWS) and Mammoth Energy Services (TUSK).
What other stocks do shareholders of Core Laboratories own?
Who are Core Laboratories' key executives?
Core Laboratories' management team includes the folowing people:
- Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
- Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)
- Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
- Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
- Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations
Who are Core Laboratories' major shareholders?
Core Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Clearbridge Investments LLC (10.16%), WCM Investment Management LLC (7.02%), Kayne Anderson Rudnick Investment Management LLC (3.50%), Kayne Anderson Rudnick Investment Management LLC (3.15%), JPMorgan Chase & Co. (2.71%) and Neuberger Berman Group LLC (1.20%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories.
Which institutional investors are selling Core Laboratories stock?
CLB stock was sold by a variety of institutional investors in the last quarter, including WCM Investment Management LLC, Clearbridge Investments LLC, Comerica Bank, Howland Capital Management LLC, BTIM Corp., Victory Capital Management Inc., Mcdonald Capital Investors Inc. CA and Loring Wolcott & Coolidge Fiduciary Advisors LLP MA. View Insider Buying and Selling for Core Laboratories.
Which institutional investors are buying Core Laboratories stock?
CLB stock was acquired by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Forsta AP Fonden, Lazard Asset Management LLC, Royce & Associates LP, Wells Fargo & Company MN, Principal Financial Group Inc., Scout Investments Inc. and Carillon Tower Advisers Inc.. View Insider Buying and Selling for Core Laboratories.
How do I buy shares of Core Laboratories?
Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Core Laboratories' stock price today?
One share of CLB stock can currently be purchased for approximately $51.65.
How big of a company is Core Laboratories?
Core Laboratories has a market capitalization of $2.29 billion and generates $700.85 million in revenue each year. The oil and gas company earns $79.52 million in net income (profit) each year or $2.28 on an earnings per share basis. Core Laboratories employs 4,700 workers across the globe.View Additional Information About Core Laboratories.
What is Core Laboratories' official website?
How can I contact Core Laboratories?
Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]
MarketBeat Community Rating for Core Laboratories (NYSE CLB)
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
